Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Ebstein’s anomaly is a rare congenital heart defect where the tricuspid valve is malformed and displaced downward into the right ventricle, likely resulting from complex interactions between genetic predisposition and environmental factors during early fetal development. While the exact cause remains unknown in most cases, researchers are actively investigating specific genetic variations and prenatal exposures that may disrupt normal heart formation in the first trimester. What causes Ebstein’s anomaly to develop during pregnancy? Ebstein’s anomaly occurs during the first eight weeks of gestation when the heart is undergoing complex structural development.
1 people with Ebsteins Anomaly have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Ebstein’s anomaly is a rare congenital heart defect where the tricuspid valve is malformed and displaced downward into the right ventricle, likely resulting from complex interactions between genetic predisposition and environmental factors during early fetal development. While the exact cause remains unknown in most cases, researchers are actively investigating specific genetic variations and prenatal exposures that may disrupt normal heart formation in the first trimester.
Ebstein’s anomaly occurs during the first eight weeks of gestation when the heart is undergoing complex structural development. In a typical heart, the tricuspid valve sits at the junction between the right atrium and the right ventricle. In Ebstein’s anomaly, the leaflets of this valve fail to detach properly from the inner wall of the heart, causing them to be displaced downward. This creates a functional "atrialization" of the right ventricle, effectively shrinking the pumping chamber of the heart. Because this happens so early in embryonic life, the cause is rarely linked to a single event, but rather a combination of developmental disruptions that prevent the valve from anchoring in the correct position.
While most cases of Ebstein’s anomaly appear sporadically—meaning they occur without a clear family history—genetic research is ongoing. Scientists have identified that some cases may be associated with specific chromosomal abnormalities or polygenic inheritance, where multiple small genetic variations contribute to the risk. While no single "Ebstein gene" has been identified as the universal cause, familial clusters suggest that certain genetic predispositions can increase the likelihood of the defect appearing within a family. Current research is utilizing advanced genomic sequencing to identify these rare variants in families where multiple members have been diagnosed with Ebstein’s anomaly.
Environmental triggers are often cited as potential contributors to the development of Ebstein’s anomaly, particularly those that interfere with fetal heart morphogenesis. The most well-documented association is maternal exposure to lithium during the first trimester of pregnancy. Other factors currently under investigation include:
In medical research, a "cause" is a direct factor that initiates the disease process, whereas a "risk factor" increases the probability of the condition occurring. For Ebstein’s anomaly, this distinction is crucial. For example, lithium exposure is considered a strong risk factor, but it does not cause the anomaly in every fetus exposed to it; this suggests that the fetus must also have a specific genetic susceptibility to be affected. Our community of 164 members on DiseaseMaps.org highlights the diverse presentations of the condition, emphasizing that even when the etiology is unknown, the clinical impact on the heart remains a priority for long-term management.
Current medical research is shifting toward understanding the molecular signaling pathways that govern valve formation. By studying how cardiac cells migrate and differentiate, researchers hope to pinpoint exactly which "molecular switch" fails in Ebstein’s anomaly. Ongoing studies are focused on large-scale biobanking to compare the genetic profiles of patients, which may eventually lead to better prenatal counseling and improved early intervention strategies.
Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.